151 related articles for article (PubMed ID: 23233439)
1. Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles.
Bianchi A; Lux F; Tillement O; Crémillieux Y
Magn Reson Med; 2013 Nov; 70(5):1419-26. PubMed ID: 23233439
[TBL] [Abstract][Full Text] [Related]
2. Aerosol deposition in the lungs of spontaneously breathing rats using Gd-DOTA-based contrast agents and ultra-short echo time MRI at 1.5 Tesla.
Wang H; Sebrié C; Ruaud JP; Guillot G; Bouazizi-Verdier K; Willoquet G; Maître X; Darrasse L; de Rochefort L
Magn Reson Med; 2016 Feb; 75(2):594-605. PubMed ID: 25809444
[TBL] [Abstract][Full Text] [Related]
3. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 Tesla.
Loubeyre P; De Jaegere T; Bosmans H; Miao Y; Ni Y; Landuyt W; Marchal G
J Magn Reson Imaging; 1999 Mar; 9(3):447-53. PubMed ID: 10194716
[TBL] [Abstract][Full Text] [Related]
4. Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI.
Bianchi A; Dufort S; Lux F; Courtois A; Tillement O; Coll JL; Crémillieux Y
MAGMA; 2014 Aug; 27(4):303-16. PubMed ID: 24170416
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
[TBL] [Abstract][Full Text] [Related]
6. Improved vessel delineation in keyhole time-resolved contrast-enhanced MR angiography using a gadolinium doped flush.
Beranek-Chiu J; Froehlich JM; Wentz KU; Doert AN; Zollikofer CL; Eckhardt BP
J Magn Reson Imaging; 2009 May; 29(5):1147-53. PubMed ID: 19388120
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional accurate detection of lung emphysema in rats using ultra-short and zero echo time MRI.
Bianchi A; Tibiletti M; Kjørstad Å; Birk G; Schad LR; Stierstorfer B; Rasche V; Stiller D
NMR Biomed; 2015 Nov; 28(11):1471-9. PubMed ID: 26403226
[TBL] [Abstract][Full Text] [Related]
8. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
[TBL] [Abstract][Full Text] [Related]
9. Ultrashort echo time (UTE) MRI of the lung: assessment of tissue density in the lung parenchyma.
Togao O; Tsuji R; Ohno Y; Dimitrov I; Takahashi M
Magn Reson Med; 2010 Nov; 64(5):1491-8. PubMed ID: 20574988
[TBL] [Abstract][Full Text] [Related]
10. Quantitative rapid steady state T1 magnetic resonance imaging for cerebral blood volume mapping in mice: Lengthened measurement time window with intraperitoneal Gd-DOTA injection.
Perles-Barbacaru AT; Berger F; Lahrech H
Magn Reson Med; 2013 May; 69(5):1451-6. PubMed ID: 22760854
[TBL] [Abstract][Full Text] [Related]
11. Orotracheal administration of contrast agents: a new protocol for brain tumor targeting.
Bianchi A; Moncelet D; Lux F; Plissonneau M; Rizzitelli S; Ribot EJ; Tassali N; Bouchaud V; Tillement O; Voisin P; Crémillieux Y
NMR Biomed; 2015 Jun; 28(6):738-46. PubMed ID: 25921808
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional assessment of lung tissue density using a clinical ultrashort echo time at 3 tesla: a feasibility study in healthy subjects.
Lederlin M; Crémillieux Y
J Magn Reson Imaging; 2014 Oct; 40(4):839-47. PubMed ID: 24123396
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla.
Fries P; Morr D; Müller A; Lux F; Tillement O; Massmann A; Seidel R; Schäfer T; Menger MD; Schneider G; Bücker A
Rofo; 2015 Dec; 187(12):1108-15. PubMed ID: 26361379
[TBL] [Abstract][Full Text] [Related]
14. Optimizing contrast agent concentration and spoiled gradient echo pulse sequence parameters for catheter visualization in MR-guided interventional procedures: an analytic solution.
Sussman MS; Lindner U; Haider M; Kucharczyk W; Hlasny E; Trachtenberg J
Magn Reson Med; 2013 Aug; 70(2):333-40. PubMed ID: 23801423
[TBL] [Abstract][Full Text] [Related]
15. Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis.
Yoon MA; Kim SH; Park HS; Lee DH; Lee JY; Han JK; Choi BI
Invest Radiol; 2009 Oct; 44(10):641-9. PubMed ID: 19724237
[TBL] [Abstract][Full Text] [Related]
16. Early detection of lung inflammation: exploiting T1-effects of iron oxide particles using UTE MRI.
Strobel K; Hoerr V; Schmid F; Wachsmuth L; Löffler B; Faber C
Magn Reson Med; 2012 Dec; 68(6):1924-31. PubMed ID: 22368111
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.
Kremer S; Lamy J; Magnus A; Oesterle H; Jeantroux J; Trunet S; Armspach JP; Dietemann JL; de Sèze J
Neurology; 2013 Jul; 81(3):206-10. PubMed ID: 23761623
[TBL] [Abstract][Full Text] [Related]
18. Sequential fast 3D MRI following oral ingestion of Gd-DOTA: A new means to assess intestinal transit time.
Patak MA; Weishaupt D; Fröhlich JM; Debatin JF
J Magn Reson Imaging; 1999 Sep; 10(3):474-6. PubMed ID: 10508311
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Gd-DOTA-based aerosol deposition mapping in the lungs of asthmatic rats using 3D UTE-MRI.
Wang H; Sebrié C; Judé S; Maurin A; Rétif S; Le Mée M; Julea F; Dubuisson RM; Willoquet G; Bouazizi K; Darrasse L; Guillot G; Maître X; de Rochefort L
NMR Biomed; 2018 Dec; 31(12):e4013. PubMed ID: 30307075
[TBL] [Abstract][Full Text] [Related]
20. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
